Requirements for Unity of Application - Japan Patent Office
Requirements for Unity of Application - Japan Patent Office
Requirements for Unity of Application - Japan Patent Office
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
[Example 26]<br />
[Title <strong>of</strong> the Invention]<br />
16α-substitution pregnen group, and an intermediate <strong>for</strong> manufacturing the 16α-substitution<br />
pregnen group<br />
[Claims]<br />
1. A steroid compound indicated by Formula [I]<br />
[In this <strong>for</strong>mula, R 1 means phenyl or naphthyl.]<br />
2. A steroid compound indicated by Formula [II]<br />
[In this <strong>for</strong>mula, R 1 means a phenyl or naphthyl.]<br />
[Excerpt <strong>of</strong> Detailed Description <strong>of</strong> the Invention]<br />
This invention relates to a 16α-substitution pregnen group useful as an anti-inflammatory<br />
drug and an intermediate useful <strong>for</strong> manufacturing this 16α-substitution pregnen group. The<br />
steroid compound indicated by Formula [I], which has anti-inflammatory properties, is easily<br />
manufactured by treating the steroid intermediate indicated by Formula [II].<br />
[Explanation]<br />
It is recognized that the main use <strong>of</strong> a compound <strong>of</strong> the related invention (Claim 2) is a raw<br />
material (an intermediate) <strong>of</strong> a compound (a final compound) <strong>of</strong> the specified invention (Claim 1).<br />
There<strong>for</strong>e it is highly appropriate that the art <strong>of</strong> the technical field <strong>of</strong> a compound <strong>of</strong> the related<br />
invention is applied to the technical field <strong>of</strong> a compound <strong>of</strong> the specified invention. The technical<br />
fields <strong>of</strong> both inventions are technically and directly associated with each other and their<br />
industrial fields <strong>of</strong> application <strong>of</strong> them are the same.<br />
In addition, both compounds have common fundamental structures<br />
and the final compound indicated by Formula [I] is directly manufactured from an intermediate<br />
indicated by Formula [II]. There<strong>for</strong>e, it is recognized that both compounds are closely and<br />
technically associated with each other, and the substantial parts <strong>of</strong> matters in the claims <strong>of</strong> both<br />
57
Change language